Cytokine Profile in Children With Celiac Disease

NCT02244047 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: Bifidobacterium breve
DRUG: Placebo (for Bifidobacterium breve)

Sponsor

University Medical Centre Maribor

Collaborators

[object Object]